The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane
- PMID: 17158203
- DOI: 10.1210/en.2006-1086
The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane
Abstract
The relaxin receptor (LGR7, relaxin family peptide receptor 1) is a member of the leucine-rich repeat containing G protein-coupled receptors subgroup C. This and the LGR8 (relaxin family peptide receptor 2) receptor are unique in having a low-density lipoprotein class A (LDL-A) module at their N termini. This study was designed to show the role of the LDL-A in LGR7 expression and function. Point mutants for the conserved cysteines (Cys(47) and Cys(53)) and for calcium binding asparagine (Asp(58)), a mutant with deleted LDL-A domain and chimeric LGR7 receptor with LGR8 LDL-A all showed no cAMP response to human relaxins H1 or H2. We have shown that their cell surface delivery was uncompromised. The mutation of the putative N-linked glycosylation site (Asn(36)) decreased cAMP production and reduced cell surface expression to 37% of the wild-type LGR7. All point mutant, chimeric, and wild-type receptor proteins were expressed as the two forms. The immature or precursor form of the receptor was 80 kDa, whereas the mature receptor, delivered to the cell surface was 95 kDa. The glycosylation mutant was also expressed as two forms with appropriately smaller molecular masses. Deletion of the LDL-A module resulted in expression of the mature receptor only. These data suggest that the LDL-A module of LGR7 influences receptor maturation, cell surface expression, and relaxin-activated signal transduction.
Similar articles
-
Mechanisms of relaxin receptor (LGR7/RXFP1) expression and function.Ann N Y Acad Sci. 2009 Apr;1160:60-6. doi: 10.1111/j.1749-6632.2008.03826.x. Ann N Y Acad Sci. 2009. PMID: 19416160
-
Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules.J Biol Chem. 2006 Nov 17;281(46):34942-54. doi: 10.1074/jbc.M602728200. Epub 2006 Sep 8. J Biol Chem. 2006. PMID: 16963451
-
The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation.J Biol Chem. 2007 Feb 9;282(6):4172-84. doi: 10.1074/jbc.M609526200. Epub 2006 Dec 4. J Biol Chem. 2007. PMID: 17148455
-
Membrane receptors: structure and function of the relaxin family peptide receptors.Mol Cell Endocrinol. 2010 May 14;320(1-2):1-15. doi: 10.1016/j.mce.2010.02.003. Epub 2010 Feb 6. Mol Cell Endocrinol. 2010. PMID: 20138959 Review.
-
Relaxin-3, INSL5, and their receptors.Results Probl Cell Differ. 2008;46:213-37. doi: 10.1007/400_2007_055. Results Probl Cell Differ. 2008. PMID: 18236022 Review.
Cited by
-
Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism.Neuron. 2012 Jan 26;73(2):317-32. doi: 10.1016/j.neuron.2011.10.038. Neuron. 2012. PMID: 22284186 Free PMC article.
-
Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.Endocrinology. 2009 May;150(5):2419-28. doi: 10.1210/en.2008-1385. Epub 2008 Dec 30. Endocrinology. 2009. PMID: 19116340 Free PMC article.
-
Chimeric RXFP1 and RXFP2 Receptors Highlight the Similar Mechanism of Activation Utilizing Their N-Terminal Low-Density Lipoprotein Class A Modules.Front Endocrinol (Lausanne). 2013 Nov 11;4:171. doi: 10.3389/fendo.2013.00171. eCollection 2013. Front Endocrinol (Lausanne). 2013. PMID: 24273532 Free PMC article.
-
Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.Nat Commun. 2013;4:1953. doi: 10.1038/ncomms2953. Nat Commun. 2013. PMID: 23764525 Free PMC article.
-
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.Sci Rep. 2017 Jun 7;7(1):2968. doi: 10.1038/s41598-017-02916-5. Sci Rep. 2017. PMID: 28592882 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources